Latest From Biotech Now

BIO and University Organizations offer Support of STRONG Patents Act

shutterstock_26191726

On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents Act of 2015. Sponsored alongside Sen. Richard Durbin (D-IL) and Sen. Mazie Hirono (D-HI), the bill is offered as a complement to House Judiciary Committee Chairman Goodlatte’s (R-VA) Innovation Act, which many in the biotech sector see as an imbalanced bill. The STRONG Patents Act of 2015 would target the abusive practices of patent trolls in a narrowly tailored setting, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The Value of Innovation to Save and Transform Lives

lab_tech

Patients have greater hope for cures to today’s most complex and challenging diseases thanks to modern specialty medicines, which allow doctors and patients to focus on prevention and avoid hospital care altogether. With the potential to save countless lives and improve so many more, today’s innovative life-enhancing medicines and therapies provide economic value far beyond their cost. The debate surrounding the value of modern specialty medicines focuses narrowly on one aspect – cost – while Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Stop Vandalizing Science!

UC Berkeley Eucalyptus Grove

On Thursday, March 5, at 6 a.m., around 1,000 female members of Brazil’s Landless Workers’ Movement (MST) armed with sticks and knives broke into a cellulose company in San Paulo State and destroyed millions of samples of genetically modified (GM) eucalyptus saplings.  Fox News and a number of international media outlets reported. The MST said in a communique that its activists invaded the facilities of FuturaGene Brasil Tecnologia, a company owned by Suzano Papel y Celulosa where genetic modification Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

GEN Ranks Top Ten U.S. Biopharma Clusters

BIO-InternationalConvention_Graphic_115x176_v3

Yesterday, Alex Philippidis at Genetic Engineering and Biotechnology News released their annual ranking of the top 10 U.S. biopharma clusters. To rank the clusers, five criteria are considered: NIH funding, venture capital funding, number of biotech patents awarded, lab space, and jobs. Landing the number 6 spot is the Greater Philadelphia region, home to this year’s BIO International Convention. From the report: The birthplace of independence saw a nice year-over-year increase in venture capital financing, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO’s Next Generation Partnering System to Open April 2015

partnering-HP-300x312

You’ve found your lead investor. Now it’s time to get to the next stage, and the best place to do so is the 2015 BIO International Convention. You have a meeting with Pfizer at 9:00 a.m. followed by a meeting with AstraZeneca/MedImmune at 9:30 a.m. Then a 30 minute break. Then you have four meetings back to back with Sofinnova, Takeda Ventures, Gates Foundation and Merck. After a quick lunch it’s back to partnering: make Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,